Politics

Update on Toilet Paper

Published

August 12, 2023

In this episode, Mark updates his early March 2023 episode (Mises.org/Minor11) on the high price of toilet paper. He shows how economic changes, so far, in 2023 seem to have vindicated his forecast of lower toilet paper and paper towel prices. It also demonstrates how the market process works on a minor scale, even when large determinants like Amazon, Covid, and the US home construction industry get tangled up with politicians and bureaucrats.

Be sure to follow Minor Issues at Mises.org/MinorIssues.

In this article:

Rep. Miller‐Meeks’ OTC Act Might Nudge the FDA and Drug Makers Towards Making All Hormonal Contraceptives Over‐The‐Counter

Jeffrey A. Singer On the same day that the Food and Drug Administration allowed women over‐the‐counter access to one progestin‐only birth control pill, Rep....

July 14, 2023

BrilliantAchievement.com

Politics

Update on Toilet Paper

Trending

Editor's Pick

Rep. Miller‐Meeks’ OTC Act Might Nudge the FDA and Drug Makers Towards Making All Hormonal Contraceptives Over‐The‐Counter

Editor's Pick

FDA Finally Allows OTC Access to One Brand of “Minipill”—A Mini‐step in the Right Direction

Editor's Pick

House Appropriations Subcommittee Zeroes Out California High‐Speed Rail

Editor's Pick

Crypto Clarity Is Up to Congress: Taking Stock of the Latest Lummis‐Gillibrand Bill

Editor's Pick

“Suppression” or No, Most Voting‐Law Changes Don’t Alter Partisan Outcomes

You May Also Like

Editor's Pick

Rep. Miller‐Meeks’ OTC Act Might Nudge the FDA and Drug Makers Towards Making All Hormonal Contraceptives Over‐The‐Counter

Editor's Pick

FDA Finally Allows OTC Access to One Brand of “Minipill”—A Mini‐step in the Right Direction

Editor's Pick

House Appropriations Subcommittee Zeroes Out California High‐Speed Rail

Editor's Pick

Crypto Clarity Is Up to Congress: Taking Stock of the Latest Lummis‐Gillibrand Bill

Trending

Editor's Pick

Rep. Miller‐​Meeks’ OTC Act Might Nudge the FDA and Drug Makers Towards Making All Hormonal Contraceptives Over‐​The‐​Counter

Editor's Pick

FDA Finally Allows OTC Access to One Brand of “Minipill”—A Mini‐​step in the Right Direction

Editor's Pick

House Appropriations Subcommittee Zeroes Out California High‐​Speed Rail

Editor's Pick

Crypto Clarity Is Up to Congress: Taking Stock of the Latest Lummis‐​Gillibrand Bill

Editor's Pick

“Suppression” or No, Most Voting‐​Law Changes Don’t Alter Partisan Outcomes

You May Also Like

Editor's Pick

Rep. Miller‐​Meeks’ OTC Act Might Nudge the FDA and Drug Makers Towards Making All Hormonal Contraceptives Over‐​The‐​Counter

Editor's Pick

FDA Finally Allows OTC Access to One Brand of “Minipill”—A Mini‐​step in the Right Direction

Editor's Pick

House Appropriations Subcommittee Zeroes Out California High‐​Speed Rail

Editor's Pick

Crypto Clarity Is Up to Congress: Taking Stock of the Latest Lummis‐​Gillibrand Bill

Rep. Miller‐Meeks’ OTC Act Might Nudge the FDA and Drug Makers Towards Making All Hormonal Contraceptives Over‐The‐Counter

FDA Finally Allows OTC Access to One Brand of “Minipill”—A Mini‐step in the Right Direction

House Appropriations Subcommittee Zeroes Out California High‐Speed Rail

Crypto Clarity Is Up to Congress: Taking Stock of the Latest Lummis‐Gillibrand Bill

“Suppression” or No, Most Voting‐Law Changes Don’t Alter Partisan Outcomes

Rep. Miller‐Meeks’ OTC Act Might Nudge the FDA and Drug Makers Towards Making All Hormonal Contraceptives Over‐The‐Counter

FDA Finally Allows OTC Access to One Brand of “Minipill”—A Mini‐step in the Right Direction

House Appropriations Subcommittee Zeroes Out California High‐Speed Rail

Crypto Clarity Is Up to Congress: Taking Stock of the Latest Lummis‐Gillibrand Bill